These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2292528)

  • 1. Concentrations of cefpodoxime in plasma and lung tissue after a single oral dose of cefpodoxime proxetil.
    Couraud L; Andrews JM; Lecoeur H; Sultan E; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():35-40. PubMed ID: 2292528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of cefpodoxime in plasma and pleural fluid after a single oral dose of cefpodoxime proxetil.
    Dumont R; Guetat F; Andrews JM; Sultan E; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():41-6. PubMed ID: 2292529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil.
    Gehanno P; Andrews JM; Ichou F; Sultan E; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():47-51. PubMed ID: 2292530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients.
    Muller-Serieys C; Bancal C; Dombret MC; Soler P; Murciano G; Aubier M; Bergogne-Berezin E
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2099-103. PubMed ID: 1444291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses.
    Tremblay D; Dupront A; Ho C; Coussediere D; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():21-8. PubMed ID: 2292526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of cefpodoxime proxetil in hemodialysis patients.
    Borin MT; Hughes GS; Kelloway JS; Shapiro BE; Halstenson CE
    J Clin Pharmacol; 1992 Nov; 32(11):1038-44. PubMed ID: 1474165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetil.
    Borin MT; Hughes GS; Patel RK; Royer ME; Cathcart KS
    J Clin Pharmacol; 1991 Dec; 31(12):1137-45. PubMed ID: 1761737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of food on absorption of cefpodoxime proxetil oral suspension in adults.
    Borin MT; Forbes KK
    Antimicrob Agents Chemother; 1995 Jan; 39(1):273-5. PubMed ID: 7695323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.
    Borin MT; Hughes GS; Spillers CR; Patel RK
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1094-9. PubMed ID: 2393268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefpodoxime proxetil concentrations in head and neck tissues.
    Theopold HM; Matthias C; Adam D
    Infection; 1991; 19(1):41-3. PubMed ID: 2013507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the pharmacokinetics of cefpodoxime proxetil.
    Borin MT
    Drugs; 1991; 42 Suppl 3():13-21. PubMed ID: 1726203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.
    Baldwin DR; Wise R; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1992 Jul; 30(1):67-71. PubMed ID: 1429338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine.
    Kees F; Wellenhofer M; Bröhl K; Grobecker H
    Arzneimittelforschung; 1996 Apr; 46(4):435-8. PubMed ID: 8740095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist.
    Saathoff N; Lode H; Neider K; Depperman KM; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1992 Apr; 36(4):796-800. PubMed ID: 1354432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
    Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
    J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of cefpodoxime proxetil in healthy volunteers and patients with impaired renal function.
    St Peter JV; Borin MT; Hughes GS; Kelloway JS; Shapiro BE; Halstenson CE
    Antimicrob Agents Chemother; 1992 Jan; 36(1):126-31. PubMed ID: 1590677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefpodoxime in plasma and subcutaneous fluid following oral administration of cefpodoxime proxetil in male beagle dogs.
    Kumar V; Madabushi R; Lucchesi MB; Derendorf H
    J Vet Pharmacol Ther; 2011 Apr; 34(2):130-5. PubMed ID: 21395603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial tissue concentrations of cefpodoxime.
    Liu P; Müller M; Grant M; Webb AI; Obermann B; Derendorf H
    J Antimicrob Chemother; 2002 Jul; 50 Suppl():19-22. PubMed ID: 12077156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of cefpodoxime in plasma, adenoid, and tonsillar tissue after repeated administrations of cefpodoxime proxetil in children.
    Bairamis TN; Nikolopoulos TP; Kafetzis DA; Begue P; Lenfant B; Kandiloros DC; Apostolopoulos NJ
    J Antimicrob Chemother; 1996 Apr; 37(4):821-4. PubMed ID: 8722549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefpodoxime proxetil in healthy young and elderly volunteers.
    Borin MT; Ferry JJ; Forbes KK; Hughes GS
    J Clin Pharmacol; 1994 Jul; 34(7):774-81. PubMed ID: 7929873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.